IART Stock Analysis: Buy, Sell, or Hold?
IART - Integra LifeSciences Holdings
$18.69
-0.10 (-0.53%)
▼
5d:
+2.81%
30d:
+9.36%
90d:
+88.79%
HOLD
MODERATE Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Jul 30, 2026
16d
Get Alerted When IART Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IART trades at premium valuation expecting 12.0% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: IART trades at premium valuation expecting 12.0% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$17.40
Based on 5.5% avg growth
INTRINSIC VALUE TODAY
$10.81
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IART is currently trading at $18.69, which is considered extended relative to its 30-day fair value range of $17.28 to $18.34. From a valuation perspective, the stock is trading at a premium (Forward PE: 7.2) compared to its historical average (5.1). At these levels, the market is pricing in 12.0% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, IART is in a strong uptrend. The price is approaching resistance at $18.92. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (18th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IART is in a strong uptrend. The price is approaching resistance at $18.92. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (18th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$17.28 -
$18.34
Company Quality Score
60/100
(HOLD)
Options IV Signal
18th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
52.7%
Protect Your Profits
Holding IART? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 18th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($18.00)
- BEARISH: Market expects 12.0% growth - appears too optimistic based on history
Trading Range Analysis
30-Day Trading Range
$17.28 -
$18.34
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$2.09
(11.2%)
Support & Resistance Levels
Support Level
$17.01
Resistance Level
$18.92
Current Trend
Strong Uptrend
Technical data as of
Jul 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.18
Wall Street Target
$18.00
(-4.2%)
Revenue Growth (YoY)
2.4%
Earnings Growth (YoY)
0.4%
Profit Margin
-30.1%
Valuation Premium vs History
+12.0% premium
PE vs Historical
7.2 vs 5.1
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+12.0%
(market-implied from PE analysis)
1-Year Target
$21.04
(+12%)
2-Year Target
$23.57
(+25%)
3-Year Target
$26.40
(+41%)
3-Yr Target (if PE normalizes)
(PE: 7→5)
PE COMPRESSION
$18.76
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 6.9%)
$69.57
(+270%)
Base:
(SPY PE: 7.2, Growth: 6.9%)
$22.93
(+22%)
Bear:
(PE: 5.1, Growth: 6.9%)
$16.29
(-13%)
Share & Embed Analysis
Last updated: July 13, 2026 10:24 AM ET
Data refreshes hourly during market hours. Next update: 11:24 AM
Data refreshes hourly during market hours. Next update: 11:24 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IART showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$386 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 66 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$239 | 58 HOLD |
Advanced IART Option Strategies
Professional options setups generated by AI based on today's IART price and gamma walls.
